Vaccine Asia Live: Current Situation of Cervical Cancer Vaccines

Levent Shih-Jen Liu, the Associate Investigator of National Health Research Institute in Taiwan, moderated the Round Table Discussion, covering the topic of cervical cancer vaccines. Human Papilloma Virus (HPV) Vaccine, a vaccine developed to prevent cervical cancer among women, has been introduced in many countries around the world, including those in Asia. Through valuable inputs from each delegate, a clear …

Vaccine

Vaccine Asia Live: Novel Vaccines for Emerging Diseases

Most vaccines developed target infectious diseases and cancer, with cancer vaccines being listed more under therapeutic vaccines. To enlighten us on vaccines for infectious diseases, Ms Zhang Xiaoshu, Director of Business Development at BravoBio, China, presented on the topic of Novel Vaccines for Emerging Diseases. BravoBio was founded in 2011 with its  headquarters in Shanghai and multiple sites in China. …

Vaccine

Presentation: Live attenuated influenza vaccine and its clinical development in China

At the last Influenza Summit, part of World Vaccine Congress Asia, Prof.Dr. Xu Fei of Changchun BCHT Biotechnology Co. gave the following presentation entitled: Live attenuated influenza vaccine (LAIV) and its clinical development in China. Some points discussed during the presentation include: BCHT overview LAIV introduction Review of Clinical Data Development of clinical trial strategy in China Download the presentation …

China Bans the Eating of Rare Animals: could this have prevented SARS?

Will the new Chinese ban on the eating of rare animals reduce the likelihood of another SARS epidemic? In 2003 SARS (Severe acute respiratory syndrome) swept across china and surrounding countries in one of the largest epidemics of recent times. With 8273 cases, 775 deaths, and an estimated $40 billion worth of damage to worldwide economy, SARS bought China to …

Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project

RMB 60 Million Free Grant for Construction of Dedicated Production Facility  April 24, 2014 Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today that it has received notification that a RMB 60 million free government grant has been approved by China’s Ministry of Finance, National Development and Reform Commission, Ministry of Industry and Information Technology, and National Health and Family Planning Commission for …

iBio Receives Patent Allowance in China for Fusion Protein Compositions and Technology

April 24, 2014 iBio, Inc., a leader in plant-based biotechnology for developing and manufacturing biological products, reported the allowance of a Chinese patent on its lichenase fusion protein technology for therapeutic proteins and vaccines. “The invention covered by this patent enables increased efficiency in the expression of a range of commercially important proteins,” said Dr. Wayne Fitzmaurice, iBio’s vice-president of …

Round up from the World Vaccine Congress 2014

  So the World Vaccine Congress is over for its 14th year! With 80+ speakers, 40+ sponsors and over 60 sessions of scientific, corporate development and future-looking content, it was a busy few days! Opening with Dr Gregory Poland from the Mayo Clinic talking about the future of vaccinology, right from the start the focus was on what will be …

WHO update on Avian Flu in China

On 20 and 21 February 2014, the National Health and Family Planning Commission (NHFPC) of China notified WHO of nine additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus. Seven of the nine cases are males. The age range is 29 to 81 years. Cases were reported from Anhui (1), Hunan (2), Jilin (1) and Guangdong (5). One …

China’s JE vaccine gains GAVI support, enters global marketplace

China has the largest vaccine manufacturing capacity in the world, but has yet to really make its mark in the global vaccine marketplace. While Chinese firms primarily make vaccines the domestic market, an entry into global health could have a significant effect, potentially driving down vaccine prices and accelerating global immunization efforts. Up until October, however, no Chinese-made vaccine had …